Facebook
Twitter
LinkedIn
Forward
Dr.
|
This lecture will review some of the new drugs recently FDA approved for management of lymphoma such as CAR-T therapy for relapsed/refractory Mantle Cell Lymphoma or follicul
|
Webinar DescriptionBrian Colwell Jensen, MD, will review the potential cardiotoxicity associated with radiation therapy, chemotherapy, and newer targete
|
Webinar DescriptionHannah E.
|
Chemotherapy-induced neuropathy is a major clinical problem that can lead to persistent issues for cancer survivors and can even limit the use of planned chemotherapy treatme
|
Genetic sequencing technologies are increasingly applied in the oncology setting for a variety of purposes. Genetic testing of tumor specimens can help clarify a diagnosis and inform targeted therapies. Kate Foreman, MS, CGC helps us navigate this field.
|
Join Transfusion Medicine and Blood Bank Fellow, Mariama Evans, MD, for a review of transfusion reactions and their laboratory workup. Specific topics to include the most common transfusion reactions seen in cancer patients and the laboratory techniques utilized, such as Direct Antiglobulin Test (DAT) and elutions.
|
Oral chemotherapy is becoming increasingly common in treatment of various malignancies. Although oral oncolytics are extremely beneficial for patients, they also present unique challenges for patients and providers alike. Implementing oral chemotherapy often requires a multidisciplinary approach. This lecture discusses several considerations for oral chemotherapy such as prescribing, patient education, adherence, medication access, cost and insurance authorization, monitoring, supportive care, and more. We will walk through a patient case to highlight practical suggestions for successful implementation of oral chemotherapy for patients.
|
In this webinar, Angela Smith, MD, MS, FACS discusses the definition and use of electronic patient-reported outcomes (ePROs) and mobile health technology in optimizing postoperative cancer care.
|
This presentation focuses on the unique psychosocial complications related to being diagnosed with - and treated for - cancer during the COVID pandemic.
|